Answers are grounded in this paper and cite their sources.
Sera from colon carcinoma patients were used to identify tumor-associated antigens (TAAs) by screening tumor proteome resolved by 2D electrophoresis. A panel of six TAAs eliciting a serological immune response in colorectal cancer was identified, showing a modification in antigen recognition by B cells in patients as a function of colon cancer progression. The expression of these proteins was either confined or increased in tumor as compared to normal mucosa.
No takes yet. Share an insight, caveat, or question.
Monte et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: